Page 60 - 78_01

…ENFERMEDAD
DE
CHAGAS

27.
Rodriguez,
J.,
Gerpe,
A.,
Aguirre,
G.,
Kemmerling,
U.,
Piro,
O.
E.,
Aran,
V.
J.,
Maya,
J.
D.,
Olea-­-
Azar,
C.,
Gonzalez,
M.,
&
Cerecetto,
H.
(2009).
Study
of
5-­-nitroindazoles'
anti-­-Trypanosoma

cruzi
mode
of
action:
electrochemical
behaviour
and
ESR
spectroscopic
studies.
Eur
J
Med

Chem
44(4),
1545-­-1553.

28.
Boiani,
L.,
Gerpe,
A.,
Aran,
V.
J.,
Torres
de
Ortiz,
S.,
Serna,
E.,
Vera
de
Bilbao,
N.,
Sanabria,
L.,

Yaluff,
G.,
Nakayama,
H.,
Rojas
de
Arias,
A.,
Maya,
J.
D.,
Morello,
J.
A.,
Cerecetto,
H.,
&
Gonzalez,

M.
(2009).
In
vitro
and
in
vivo
antitrypanosomatid
activity
of
5-­-nitroindazoles.
Eur
J
Med

Chem
44(3),
1034-­-1040.

29.
Caterina,
M.
C.,
Perillo,
I.
A.,
Boiani,
L.,
Pezaroglo,
H.,
Cerecetto,
H.,
Gonzalez,
M.,
&
Salerno,
A.

(2008).
Imidazolidines
as
new
anti-­-Trypanosoma
cruzi
agents:
biological
evaluation
and

structure-­-activity
relationships.
Bioorg
Med
Chem
16(5),
2226-­-2234.

30.
Paéz,
J.
A.,
Campillo,
N.
E.,
Guerra,
A.,
Gonzalez,
M.,
&
Cerecetto,
H.
Una
Nueva
Familia
de

Antichagásicos
Derivados
de
2,2-­-Dióxido
de
Imidazo[4,5-­-c][1,2,6]tiadiazina.
Patente
ESP

200900225;
PCT1641-­-296.
2010
Ene
26.

31.
Bollini,
M.,
Casal,
J.
J.,
Alvarez,
D.
E.,
Boiani,
L.,
Gonzalez,
M.,
Cerecetto,
H.,
&
Bruno,
A.
M.

(2009).
New
potent
imidazoisoquinolinone
derivatives
as
anti-­-Trypanosoma
cruzi
agents:

biological
evaluation
and
structure-­-activity
relationships.
Bioorg
Med
Chem
17(4),
1437-­-
1444.

32.
Boiani,
M.,
Cerecetto,
H.,
Gonzalez,
M.,
&
Gasteiger,
J.
(2008).
Modeling
anti-­-Trypanosoma

cruzi
activity
of
N-­-oxide
containing
heterocycles.
J
Chem
Inf
Model
48(1),
213-­-219.

33.
Cerecetto,
H.,
&
Gonzalez,
M.
(2008).
Anti-­-T.
cruzi
agents:
our
experience
in
the
evaluation
of

more
than
five
hundred
compounds.
Mini
Rev
Med
Chem
8(13),
1355-­-1383.

34.
Bettiol,
E.,
Samanovic,
M.,
Murkin,
A.
S.,
Raper,
J.,
Buckner,
F.,
&
Rodriguez,
A.
(2009).

Identification
of
Three
Classes
of
Heteroaromatic
Compounds
with
Activity
against

Intracellular
Trypanosoma
cruzi
by
Chemical
Library
Screening.
PLoS
Negl
Trop
Dis
3(2),

e384.

35.
da
Cruz,
M.
Q.,
Brascher,
H.
M.,
Vargens,
J.
R.,
&
Oliveira-­-Lima,
A.
(1991).
Effect
of
actinomycin

D
on
Trypanosoma
cruzi.
Experientia
47(1),
89-­-92.

36.
Cruz,
F.
S.,
Marr,
J.
J.,
&
Berens,
R.
L.
(1980).
Prevention
of
transfusion-­-induced
Chagas'

disease
by
amphotericin
B.
Am
J
Trop
Med
Hyg
29(5),
761-­-765.

37.
McCabe,
R.
(1988).
Failure
of
ketoconazole
to
cure
chronic
murine
Chagas'
disease.
J
Infect

Dis
158(6),
1408-­-1409.

38.
McCabe,
R.
E.,
Remington,
J.
S.,
&
Araujo,
F.
G.
(1984).
Ketoconazole
inhibition
of
intracellular

multiplication
of
Trypanosoma
cruzi
and
protection
of
mice
against
lethal
infection
with
the

organism.
J
Infect
Dis
150(4),
594-­-601.

39.
Apt,
W.,
Heitmann,
I.,
Jercic,
I.,
Jofré,
L.,
Muñoz,
P.,
Noemí,
I.,
San
Martín,
A.
M.,
Sapunar,
J.,

Torres,
M.,
&
Zulantay,
I.
(2008).
[Part
VI.
Antiparasitic
treatment
for
Chagas
disease].
Rev

Chilena
Infectol
25(5),
384-­-389,
discussion
387.

40.
Apt,
W.,
Arribada,
A.,
Zulantay,
I.,
Solari,
A.,
Sanchez,
G.,
Mundaca,
K.,
Coronado,
X.,
Rodriguez,

J.,
Gil,
L.
C.,
&
Osuna,
A.
(2005).
Itraconazole
or
allopurinol
in
the
treatment
of
chronic

American
trypanosomiasis:
the
results
of
clinical
and
parasitological
examinations
11
years

post-­-treatment.
Ann
Trop
Med
Parasitol
99(8),
733-­-741.

41.
Zulantay,
I.,
Apt,
W.,
Rodriguez,
J.,
Venegas,
J.,
&
Sanchez,
G.
(1998).
[Serologic
evaluation
of

treatment
of
chronic
Chagas
disease
with
allopurinol
and
itraconazole].
Rev
Med
Chil
126(3),

265-­-270.

42.
Oprea,
T.,
Mannhold,
R.,
Kubinyi,
H.,
&
Folkers,
G.
(2006).
Chemoinformatics
in
Drug

Discovery.
Wiley-­-VCH.

43.
Koch,
W.,
&
Holthausen,
M.
C.
(2001).
A
Chemist’s
Guide
to
Density
Functional
Theory.
3ª

edn.
Wiley-­-VCH
Verlag
GmbH.

57